Literature DB >> 11289049

The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121).

B V Costanzo1, V Trischitta, R Di Paola, D Spampinato, A Pizzuti, R Vigneri, L Frittitta.   

Abstract

When overexpressed, the membrane glycoprotein PC-1 may play a role in human insulin resistance through the inhibition of insulin receptor (IR) autophosphorylation. A PC-1 variant (K121Q, with lysine 121 replaced by glutamine) is also associated with whole-body insulin resistance when not overexpressed. To better understand the effects of the Q allele on IR function and downstream signaling, we transfected cultured cells with cDNAs for either the Q or the K alleles. In human MCF-7 cells, the Q allele was severalfold more effective (P < 0.05-0.01) than the K allele in reducing insulin stimulation of IR autophosphorylation, insulin receptor substrate-1 phosphorylation, phosphatidylinositol 3-kinase activity, glycogen synthesis, and cell proliferation. Similar data on IR autophosphorylation inhibition were also obtained in mouse R-/hIR and human HEK 293 cell lines. In transfected MCF-7 cells, 125I-labeled insulin binding and IR content were unchanged, and PC-1 overexpression did not influence IGF-1 stimulation of IGF-1 receptor autophosphorylation. Both the Q and K alleles directly interacted with the IR, as documented by coimmunoprecipitation assays. This interaction was greater for the Q allele than for the K allele (P < 0.01), suggesting that direct PC-1-IR interactions are important for the PC-1 inhibitory effect on insulin signaling. In conclusion, the Q allele has stronger inhibitory activity on IR function and insulin action than the more common K allele, and this is likely a consequence of the intrinsic characteristics of the molecule, which more strongly interacts with the IR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289049     DOI: 10.2337/diabetes.50.4.831

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  39 in total

1.  Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1.

Authors:  Rik Gijsbers; Hugo Ceulemans; Mathieu Bollen
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

2.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Authors:  Salvatore De Cosmo; Antonio Minenna; Yuan-Yuan Zhang; Ryan Thompson; Robert Thompson; Giuseppe Miscio; Monica Vedovato; Anna Rauseo; Alois Saller; Sandra Mastroianno; Fabio Pellegrini; Roberto Trevisan; Paola Fioretto; Alessandro Doria; Vincenzo Trischitta
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

3.  The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

Authors:  K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

4.  Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

Authors:  Yael Nadel; Joanna Lecka; Yocheved Gilad; Gal Ben-David; Daniel Förster; Georg Reiser; Sarah Kenigsberg; Jean Camden; Gary A Weisman; Hanoch Senderowitz; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2014-05-30       Impact factor: 7.446

5.  Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.

Authors:  R Saxena; C K Welt
Journal:  Acta Diabetol       Date:  2012-03-03       Impact factor: 4.280

6.  Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling.

Authors:  Kazuki Kato; Hiroshi Nishimasu; Shinichi Okudaira; Emiko Mihara; Ryuichiro Ishitani; Junichi Takagi; Junken Aoki; Osamu Nureki
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

7.  The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Authors:  Philipp Eller; Wilfried Schgoer; Thomas Mueller; Ivan Tancevski; Egon Demetz; Kristina Duwensee; Andreas Ritsch; Meinhard Haltmayer; Josef R Patsch
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

8.  ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2006-05-10

Review 9.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

10.  The role of HSP70 on ENPP1 expression and insulin-receptor activation.

Authors:  Antonella Marucci; Giuseppe Miscio; Vincenzo Trischitta; Rosa Di Paola; Libera Padovano; Watip Boonyasrisawat; Jose C Florez; Alessandro Doria
Journal:  J Mol Med (Berl)       Date:  2008-12-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.